Cargando…
Plasmatic markers in hemorrhagic stroke
Stroke is the third most common cause of death in the United States and it is the leading cause of disability. Early diagnosis and immediate therapeutic interventions are important factors to reduce the extent of brain tissue damage and the risk of stroke–related death. A rapid blood test that can c...
Autores principales: | Marginean, IC, Stanca, DM, Vacaras, V, Soritau, O, Margiean, M, Muresanu, DF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124268/ https://www.ncbi.nlm.nih.gov/pubmed/21776296 |
Ejemplares similares
-
Plasmatic markers for early diagnostic and treatment
decisions in ischemic stroke
por: Stanca, DM, et al.
Publicado: (2015) -
GFAP and antibodies against NMDA receptor subunit NR2 as biomarkers for acute cerebrovascular diseases
por: Stanca, Delia Maria, et al.
Publicado: (2015) -
Predictors of Short-Term Mortality in Patients with Ischemic Stroke
por: Iluţ, Silvina, et al.
Publicado: (2023) -
Multiple strokes and cerebral microangiopathy in a patient with Churg-Strauss syndrome
por: Văcăraş, Vitalie, et al.
Publicado: (2021) -
Interleukin-6 Plasmatic Levels in Patients with Head Trauma and Intracerebral Hemorrhage
por: Antunes, Alessandra Armstrong, et al.
Publicado: (2010)